GGrantIndex
Sort

4,870 grants matching glp 1

Gene Therapy And Neurodegeneration

$188,635
Brandon Harvey · National Institute On Drug Abuse · ZIA · FY2009 · DA

Biorepository and Pathology Core

$188,556
Michael Clare-Salzler · University Of Florida · P01 · FY2015 · AI

A study of hormone-expressing taste cells: in vivo and in vitro

$188,439
Josephine Earley · National Institute On Aging · ZIA · FY2017 · AG

Biorepository and Pathology Core

$188,348
Michael Clare-Salzler · University Of Florida · P01 · FY2014 · AI

Developing a provider-facing intervention to address cost-related medication restrictions and improve medication use in patients with type 2 diabetes

$188,134
Jing Luo · University Of Pittsburgh At Pittsburgh · K23 · FY2024 · DK

Developing a provider-facing intervention to address cost-related medication restrictions and improve medication use in patients with type 2 diabetes

$188,126
Jing Luo · University Of Pittsburgh At Pittsburgh · K23 · FY2022 · DK

Developing a provider-facing intervention to address cost-related medication restrictions and improve medication use in patients with type 2 diabetes

$188,100
Jing Luo · University Of Pittsburgh At Pittsburgh · K23 · FY2023 · DK

Core B: Clinical

$188,032
Joseph S Dillon · University Of Iowa · P50 · FY2025 · CA

Autophagy in Diabetic Kidney Disease

$187,928
Christine Limonte · University Of Washington · K23 · FY2024 · DK

Autophagy in Diabetic Kidney Disease

$187,916
Christine Limonte · University Of Washington · K23 · FY2025 · DK

Physiologic response to bariatric surgery and the impact of adjunct semaglutide - in adolescents (the PRESSURE trial)

$187,801
Jaime M. Moore · University Of Colorado Denver · K23 · FY2023 · HL

Phase I clinical trial of an immunoadhesin antitoxin for anthrax

$187,765
Keith Wycoff · Planet Biotechnology, Inc. · R34 · FY2013 · AI

Cyclic di-GMP-dependent regulation of metabolism and virulence in Borrelia burgdorferi

$187,750
Xiaofeng Frank Yang · Indiana University Indianapolis · R21 · FY2016 · AI

Physiologic response to bariatric surgery and the impact of adjunct semaglutide - in adolescents (the PRESSURE trial)

$187,699
Jaime M. Moore · University Of Colorado Denver · K23 · FY2024 · HL

BPA: Cellular and epigenetic effects on the urethra

$186,606
Frederick S Vom Saal · University Of Missouri-Columbia · U01 · FY2014 · ES

Biomechatronics Device for Diagnosis/Therapy of Anorectal Disorders

$185,966
William Combs · 3dt Holdings, Llc · R44 · FY2021 · DK

Exploring Mechanisms of Changes in Glucose Homeostasis After Bariatric Surgery: Comparing Vertical Sleeve Gastrectomy and Roux-en-Y Gastric Bypass

$185,748
Clare Jung Eun Lee · Johns Hopkins University · K23 · FY2016 · DK

Vector Core

$185,698
Barry J. Byrne · Johns Hopkins University · P01 · FY2012 · HL

Preclinical Testing of Splice Modulating Oligonucleotides Targeting SCN8A to Treat Dravet Syndrome

$185,688
Melanie K Tallent · Lifesplice Pharma, Llc · R43 · FY2019 · NS

BPA: Cellular and epigenetic effects on the urethra

$185,041
Frederick S Vom Saal · University Of Missouri-Columbia · U01 · FY2013 · ES

Phase II Evaluation of Tirzepatide in Adults with Alcohol Use Disorder and Overweight or Obesity

$184,782
Christian S Hendershot · University Of Southern California · R21 · FY2025 · AA

Effect of dipeptidyl peptidase 4 inhibition on growth hormone secretion

$184,248
Jessica K Devin · Vanderbilt University Medical Center · K23 · FY2017 · HL

Sweet taste receptors and glucose metabolism in healthy and T2DM humans

$184,182
Karen L Teff · Monell Chemical Senses Center · R21 · FY2012 · DK

Physiologic response to bariatric surgery and the impact of adjunct semaglutide - in adolescents (the PRESSURE trial)

$184,109
Jaime M. Moore · University Of Colorado Denver · K23 · FY2025 · HL

CONTROL OF MEIOSIS AND GERMLINE PROLIFERATION

$183,759
Vanderbilt University · R01 · FY2000 · GM